ImmunityBio Inc. Common Stock vs Vodafone Group Plc American Depositary Shares — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while Vodafone Group Plc American Depositary Shares trades at $16.5 (market cap $39.26B). The key difference: Vodafone Group Plc American Depositary Shares is far larger — about 3.8× ImmunityBio Inc. Common Stock's market cap, and Vodafone Group Plc American Depositary Shares pays a 3.2% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Vodafone Group Plc American Depositary Shares for 0 Days on average.
| IBRX | VOD | |
|---|---|---|
Market Cap | $10.33B | $39.26B |
Volume | 11,745,198 | 4,020,412 |
Sector | Health | Media |
52-Week High | $11.55 | $17.68 |
52-Week Low | $1.98 | $11.17 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $84.62B |
Dividend Yield | — | 3.2% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Vodafone provides mobile, fixed-line, broadband, and business communications services. It operates across Europe and Africa.
Read more on VOD →